4//SEC Filing
PORTNOY DAVID 4
Accession 0001193125-25-277890
CIK 0000862692other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 5:01 PM ET
Size
24.3 KB
Accession
0001193125-25-277890
Insider Transaction Report
Form 4
PORTNOY DAVID
DirectorChairman, Co-CEO10% Owner
Transactions
- Award
Common Stock
2025-11-11$4.13/sh+2,474$10,218→ 840,510 total - Award
Common Stock
2025-11-10$4.18/sh+1,026$4,289→ 838,036 total - Award
Common Stock
2025-11-12$4.12/sh+2,040$8,405→ 842,550 total
Holdings
- 107,403(indirect: By Spouse)
Common Stock
- 50,000
Stock Option
Exercise: $4.77From: 2023-01-03Exp: 2028-01-03→ Common Stock (50,000 underlying) - 50,000
Stock Option
Exercise: $6.47From: 2023-12-22Exp: 2028-12-22→ Common Stock (50,000 underlying) - 11,398(indirect: As Custodian for son)
Common Stock
- 23,636
Stock Option
Exercise: $7.28From: 2019-12-20Exp: 2029-12-20→ Common Stock (23,636 underlying) - 50,000
Stock Option
Exercise: $4.30From: 2022-12-23Exp: 2027-12-23→ Common Stock (50,000 underlying) - 57,306(indirect: By Corporation)
Common Stock
- 161,833(indirect: By Corporation)
Common Stock
- 164,182(indirect: By 401(k))
Common Stock
- 268,878(indirect: By IRA)
Common Stock
- 50,000
Stock Option
Exercise: $8.08From: 2025-01-21Exp: 2030-01-21→ Common Stock (50,000 underlying) - 11,537(indirect: As Custodian for son)
Common Stock
- 10,939(indirect: As Custodian for son)
Common Stock
- 59,027(indirect: By LLC)
Common Stock
- 26,243
Stock Option
Exercise: $7.53From: 2019-08-30Exp: 2029-08-30→ Common stock (26,243 underlying) - 280,000
Stock Option
Exercise: $12.27From: 2021-12-22Exp: 2028-12-22→ Common Stock (280,000 underlying)
Footnotes (9)
- [F1]The price reported is a weighted average price of $4.13. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]The price reported is a weighted average price of $4.12. The reporting person undertakes to provide to Cryo-Cell International, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F3]Shares of Common Stock held by PartnerCommunity, Inc., as to which David I. Portnoy may be deemed beneficial owner as the Chairman of the Board and Secretary.
- [F4]Shares of common stock held by uTIPu, Inc. as to which David Portnoy may be deemed the beneficial owner as the Chairman of the Board and Secretary.
- [F5]Shares of common stock held by Mayim Limited Partnership as is David Portnoy may be deemed the beneficial owner as the managing member and owner of Mayim Management, LLC, which is the general partner of Mayim Management Limited Partnership, which is the general partner of Mayim Investment Limited Partnership.
- [F6]Stock options will vest immediately if the price of the Company's common stock reaches $25.00 per share during the seven-year option term.
- [F7]8,750 stock options vest upon issuance, 8,749 options vest on 1/2/2024, 21,000 options vest on 1/2/2025 and 11,501 options vest on 1/2/2026.
- [F8]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.
- [F9]Stock options vest 1/3 upon issuance, 1/3 on January 21, 2026 and 1/3 on January 21, 2027.
Documents
Issuer
CRYO CELL INTERNATIONAL INC
CIK 0000862692
Entity typeother
Related Parties
1- filerCIK 0001315416
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 5:01 PM ET
- Size
- 24.3 KB